Paul Rava Selected Research

Dihydropyrimidine Dehydrogenase Deficiency

3/2017

Capecitabine-Induced Severe Toxicity Secondary to DPD Deficiency and Successful Treatment with Low Dose 5-Fluorouracil.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul Rava Research Topics

Disease

3	Neoplasms (Cancer) 01/2020 - 07/2016
3	Brain Neoplasms (Brain Tumor) 08/2017 - 08/2013
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 09/2020
2	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 02/2012 - 05/2003
1	Pathologic Complete Response 09/2020
1	Fibrosis (Cirrhosis) 09/2020
1	Necrosis 08/2017
1	Dihydropyrimidine Dehydrogenase Deficiency 03/2017
1	Craniopharyngioma (Craniopharyngiomas) 09/2016
1	Central Nervous System Diseases (CNS Diseases) 01/2015
1	Neoplasm Metastasis (Metastasis) 08/2013
1	Immune System Diseases (Immune Disorders) 06/2008
1	Inflammation (Inflammations) 06/2008

Drug/Important Bio-Agent (IBA)

3	LipidsIBA 02/2012 - 05/2003
2	GadoliniumIBA 07/2016 - 01/2015
2	Lipoproteins (Lipoprotein)IBA 02/2012 - 05/2003
1	Capecitabine (Xeloda)FDA Link 03/2017
1	Fluorouracil (Carac)FDA LinkGeneric 03/2017
1	beta CateninIBA 09/2016
1	O(4)-methylthymidine triphosphateIBA 02/2012
1	Apolipoproteins B (ApoB)IBA 02/2012
1	Triglycerides (Triacylglycerol)IBA 02/2012
1	ApolipoproteinsIBA 02/2012
1	microsomal triglyceride transfer proteinIBA 06/2008

Therapy/Procedure

6	Radiotherapy 01/2021 - 08/2013
2	Liver Transplantation 01/2021 - 09/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Retreatment 08/2017
1	Therapeutics 09/2016